One Pharma's issue becomes another one's fine. BD
NEW YORK (Associated Press) - Diversified health care company Johnson & Johnson will pay $511,000 to settle federal allegations that a plant in Lititz, Pa., it acquired in 2006 violated paperwork regulations for controlled substances, according to court documents. The company's McNeil unit acquired the plant when J&J bought Pfizer Inc.'s consumer health care unit in 2006. The settlement is dated July 24.
0 comments :
Post a Comment